• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膳食酚酸通过肠道微生物群改善非酒精性脂肪性肝病的作用及机制的研究进展

Research progress regarding the effect and mechanism of dietary phenolic acids for improving nonalcoholic fatty liver disease via gut microbiota.

作者信息

Ji Lin, Deng Huan, Xue Huimin, Wang Jiting, Hong Kexin, Gao Yunxiao, Kang Xiping, Fan Guanghe, Huang Weidong, Zhan Jicheng, You Yilin

机构信息

College of Food Science and Nutritional Engineering, Beijing Key Laboratory of Viticulture and Enology, China Agricultural University, Beijing, China.

出版信息

Compr Rev Food Sci Food Saf. 2023 Mar;22(2):1128-1147. doi: 10.1111/1541-4337.13106. Epub 2023 Jan 30.

DOI:10.1111/1541-4337.13106
PMID:36717374
Abstract

Phenolic acids (PAs), a class of small bioactive molecules widely distributed in food and mainly found as secondary plant metabolites, present significant advantages such as antioxidant activity and other health benefits. The global epidemic of nonalcoholic fatty liver disease (NAFLD) is becoming a serious public health problem. Existing studies showed that gut microbiota (GM) dysbiosis is highly associated with the occurrence and development of NAFLD. In recent years, progress has been made in the study of the relationship among PA compounds, GM, and NAFLD. PAs can regulate the composition and functions of the GM to promote human health, while GM can increase the dietary sources of PAs and improve its bioavailability. This paper discussed PAs, GM, and their interrelationship while introducing several representative dietary PA sources and examining the absorption and metabolism of PAs mediated by GM. It also summarizes the effect and mechanisms of PAs in improving and regulating NAFLD via GM and their metabolites. This helps to better evaluate the potential preventive effect of PAs on NAFLD via the regulation of GM and expands the utilization of PAs and PA-rich food resources.

摘要

酚酸(PAs)是一类广泛分布于食物中的小分子生物活性分子,主要作为植物次生代谢产物存在,具有抗氧化活性等显著优势以及其他对健康有益的功效。非酒精性脂肪性肝病(NAFLD)的全球流行正成为一个严重的公共卫生问题。现有研究表明,肠道微生物群(GM)失调与NAFLD的发生和发展高度相关。近年来,在PA化合物、GM和NAFLD之间关系的研究方面取得了进展。PAs可以调节GM的组成和功能以促进人类健康,而GM可以增加PAs的膳食来源并提高其生物利用度。本文在介绍几种具有代表性的膳食PA来源并研究GM介导的PAs吸收和代谢的同时,讨论了PAs、GM及其相互关系。它还总结了PAs通过GM及其代谢产物改善和调节NAFLD的作用及机制。这有助于更好地评估PAs通过调节GM对NAFLD的潜在预防作用,并扩大PAs和富含PA的食物资源的利用。

相似文献

1
Research progress regarding the effect and mechanism of dietary phenolic acids for improving nonalcoholic fatty liver disease via gut microbiota.膳食酚酸通过肠道微生物群改善非酒精性脂肪性肝病的作用及机制的研究进展
Compr Rev Food Sci Food Saf. 2023 Mar;22(2):1128-1147. doi: 10.1111/1541-4337.13106. Epub 2023 Jan 30.
2
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?益生菌在非酒精性脂肪性肝病中的作用:肠道微生物组是否重要?
Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837.
3
Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease.ω-3 脂肪酸与肠道微生物群:非酒精性脂肪性肝病的相互作用。
Dig Dis Sci. 2020 Mar;65(3):906-910. doi: 10.1007/s10620-020-06117-5.
4
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.回肠胆汁酸转运蛋白抑制剂通过改善非酒精性脂肪性肝病模型小鼠肠道微生物失调改善肝脂肪变性。
mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 6.
5
Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.肠道微生物群和胆汁酸部分介导了成纤维细胞生长因子21对蛋氨酸-胆碱缺乏饮食诱导的非酒精性脂肪性肝病小鼠的改善作用。
Free Radic Biol Med. 2023 Feb 1;195:199-218. doi: 10.1016/j.freeradbiomed.2022.12.087. Epub 2022 Dec 28.
6
Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut-Liver Axis.多糖通过调控肠-肝轴对非酒精性脂肪性肝病治疗作用的研究进展。
Int J Mol Sci. 2022 Oct 3;23(19):11710. doi: 10.3390/ijms231911710.
7
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications.非酒精性脂肪性肝病中的肠道菌群失调:发病机制、诊断和治疗意义。
Front Cell Infect Microbiol. 2022 Nov 8;12:997018. doi: 10.3389/fcimb.2022.997018. eCollection 2022.
8
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.台湾经活检证实的非酒精性脂肪性肝病患者的肠道微生物失调:一项横断面研究。
Nutrients. 2020 Mar 19;12(3):820. doi: 10.3390/nu12030820.
9
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.了解肠道微生物组和微生物代谢物在非酒精性脂肪性肝病中的作用:当前的证据和观点。
Biomolecules. 2021 Dec 31;12(1):56. doi: 10.3390/biom12010056.
10
Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date.营养干预靶向非酒精性脂肪性肝病肠道菌群的研究进展
Int J Environ Res Public Health. 2021 Feb 8;18(4):1616. doi: 10.3390/ijerph18041616.

引用本文的文献

1
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.针对代谢紊乱的肠道微生物群靶向疗法:对益生菌发酵草药生物活性成分协同作用的机制洞察
Int J Mol Sci. 2025 Jun 7;26(12):5486. doi: 10.3390/ijms26125486.
2
Targeting mitochondria with natural polyphenols for treating Neurodegenerative Diseases: a comprehensive scoping review from oxidative stress perspective.从氧化应激角度出发,利用天然多酚靶向线粒体治疗神经退行性疾病:一项全面的范围综述
J Transl Med. 2025 May 23;23(1):572. doi: 10.1186/s12967-025-06605-0.
3
Protocatechuic Acid Protects Mice Against Non-Alcoholic Fatty Liver Disease by Attenuating Oxidative Stress and Improving Lipid Profile.
原儿茶酸通过减轻氧化应激和改善血脂状况保护小鼠免受非酒精性脂肪性肝病的侵害。
Rep Biochem Mol Biol. 2024 Jul;13(2):218-230. doi: 10.61186/rbmb.13.2.218.
4
Protective Effect of Modified Suanmei-Tang on Metabolic-Associated Fatty Liver Disease: An Integrated Strategy of Network Pharmacology, Metabolomics, and Transcriptomics.酸梅汤改良方防治代谢相关性脂肪性肝病的作用:网络药理学、代谢组学和转录组学的综合策略。
Drug Des Devel Ther. 2024 Nov 13;18:5161-5182. doi: 10.2147/DDDT.S478072. eCollection 2024.
5
Polyphenols improve non-alcoholic fatty liver disease via gut microbiota: A comprehensive review.多酚通过肠道微生物群改善非酒精性脂肪性肝病:综述
Food Sci Nutr. 2024 Jun 7;12(8):5341-5356. doi: 10.1002/fsn3.4178. eCollection 2024 Aug.
6
Exploring the Role of Phenolic Compounds in Chronic Kidney Disease: A Systematic Review.探讨酚类化合物在慢性肾脏病中的作用:系统评价。
Molecules. 2024 May 30;29(11):2576. doi: 10.3390/molecules29112576.
7
Composition of Whole Grain Dietary Fiber and Phenolics and Their Impact on Markers of Inflammation.全谷物膳食纤维和酚类物质的组成及其对炎症标志物的影响。
Nutrients. 2024 Apr 3;16(7):1047. doi: 10.3390/nu16071047.
8
Açaí ( Mart.) in Health and Disease: A Critical Review.阿萨伊(Mart.)在健康与疾病中的作用:批判性评价。
Nutrients. 2023 Feb 16;15(4):989. doi: 10.3390/nu15040989.